Chemicals companies are investing in new technologies and completing small M&A deals, mainly in analytics, biotech, agriculture, and healthcare.
The chemical supplier industry has seen unprecedented consolidation over the past two years, with blockbuster deals between Dow and DuPont, Monsanto and Bayer, and Syngenta and ChemChina.
With the industry landscape shifting, how are chemical companies responding in the private markets?
Chemical suppliers are heavily invested in analytics and biotech companies, many through their venture arms. These companies are also making “bolt-on” acquisitions, where the purchased business easily fits into the acquirer’s model. Some chemical companies are acquiring firms to build adjacent products, like analytics platforms.
We used CB Insights data to analyze the investing and M&A activity of the most active chemicals companies over the past two years. Companies mentioned include: